EPISODE · Jan 10, 2025 · 27 MIN
How Aeternity Achieved Unicorn Status and What Followed – with Nikola Stojanov, CEO and Co-founder | S4 E53
from Web3 CMO Stories · host Joeri Billast & Nikola Stojanov
Send us Fan MailNikola Stojanov shares his journey from the pharmaceutical industry to blockchain innovation, highlighting the transformation of Aeternity and the launch of Hyperchains. This episode explores challenges in the blockchain landscape, the power of community engagement, and how to create your own blockchain. • Nikola's journey from pharmaceuticals to blockchain • The challenges faced during Aeternity's rapid growth • Introduction of hyperchains and its unique offerings • The importance of community feedback in development • Encouraging listeners to spin up their own hyperchainThis episode was recorded through a Descript call on December 20, 2024. Read the blog article and show notes here: https://webdrie.net/how-aeternity-achieved-unicorn-status-and-what-followed-with-nikola-stojanov-ceo-and-co-founder/.......................................................................... 📘 Read The Future CMO: Amazon 👥 Join the Future CMO Community 🌿 Explore Sintra Synergies Retreat 💼 Connect on LinkedIn..........................................................................
Embed this episode
What this episode covers
Send us Fan Mail Nikola Stojanov shares his journey from the pharmaceutical industry to blockchain innovation, highlighting the transformation of Aeternity and the launch of Hyperchains. This episode explores challenges in the blockchain landscape, the power of community engagement, and how to create your own blockchain. • Nikola's journey from pharmaceuticals to blockchain • The challenges faced during Aeternity's rapid growth • Introduction of hyperchains and its unique offerings • The...
NOW PLAYING
How Aeternity Achieved Unicorn Status and What Followed – with Nikola Stojanov, CEO and Co-founder | S4 E53
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.